7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Medical Condition

Inherited Thrombophilia

Inherited thrombophilia is a genetic tendency to form blood clots. Learn about symptoms, causes, how it is diagnosed, and possible treatment options.

HematologyICD-10: D68.5
Doctor consulting with elderly patient in hospital room.
Condition at a Glance
ICD-10 codeD68.5
SpecialtyHematology
Specialists2 doctors available

Quick answer

Inherited thrombophilia is a genetic tendency to form blood clots, caused by inherited changes in clotting proteins such as Factor V Leiden, the prothrombin mutation, or deficiencies of protein C, protein S, or antithrombin. It causes no symptoms itself; problems arise only if a clot forms, and treatment focuses on preventing and treating clots with anticoagulants.

What is inherited thrombophilia?

Inherited thrombophilia is a condition in which a person is born with a genetic change that makes their blood more likely to clot than usual. The word thrombophilia simply means a tendency toward thrombosis, and thrombosis is the medical term for a blood clot forming inside a blood vessel. When the cause is a gene passed down from a parent, doctors call it inherited (or hereditary) thrombophilia, to distinguish it from acquired thrombophilia, which develops later in life because of illness, medication, or other circumstances.

Having inherited thrombophilia does not mean a person will definitely develop a clot. Many people carry one of these genetic changes and never have a problem. Instead, the condition raises the baseline risk, so that when other factors are added, such as surgery, pregnancy, long periods of immobility, or hormone-containing medicines, a clot becomes more likely than it would be for someone without the gene change.

The condition can affect people of any age and any background, although the frequency of specific gene changes varies between populations. It is often first suspected when a person has a blood clot at a young age, has clots more than once, has a clot in an unusual location, or has several close relatives who have had clots. Because it is genetic, it is present from birth, but symptoms, if they ever appear, usually develop in adulthood.

Inherited thrombophilia symptoms

Inherited thrombophilia itself causes no symptoms. It is a hidden tendency, not an illness you can feel. Symptoms only appear if a clot actually forms, and the symptoms then depend on where the clot is. The two most common clot-related problems are deep vein thrombosis (DVT), a clot in a deep vein usually in the leg or pelvis, and pulmonary embolism (PE), which happens when part of a clot breaks off and travels to the lungs.

Common signs of a deep vein thrombosis may include:

  • Swelling in one leg (or, less often, one arm), usually not both
  • Pain, cramping, or tenderness, often starting in the calf
  • Skin that feels warm to the touch over the affected area
  • Redness or a change in skin color over the vein
  • Veins near the surface that look more prominent than usual

Possible signs of a pulmonary embolism may include:

  • Sudden shortness of breath, at rest or with mild activity
  • Sharp chest pain that may worsen when breathing in deeply or coughing
  • A rapid or irregular heartbeat
  • Coughing, sometimes with blood-streaked mucus
  • Lightheadedness, fainting, or a feeling of anxiety without a clear reason

Less commonly, clots may form in unusual places such as the veins of the brain, the abdomen, or the liver, producing headaches, abdominal pain, or other symptoms that depend on the organ involved. In some women, inherited thrombophilia is first considered after repeated pregnancy loss or certain pregnancy complications, although the connection is complex and doctors do not agree on how strong it is for every gene change.

Symptoms do not differ by which gene is affected. A person with one type of inherited thrombophilia and a person with another will have the same symptoms if they develop a DVT. What varies between types is how much the risk is raised, not how a clot feels once it happens. People who inherit two copies of a gene change, or changes in more than one gene, generally have a higher risk than those with a single change.

Causes and risk factors

Blood clotting normally depends on a careful balance between proteins that promote clotting and proteins that limit or dissolve clots. Inherited thrombophilia causes arise when a gene change tips that balance toward clotting, either by producing too much of a clot-promoting protein, by making a protein resistant to being switched off, or by reducing a natural anticlotting protein.

The most frequently identified inherited thrombophilia causes include:

  • Factor V Leiden: a change in the gene for clotting factor V that makes the protein harder for the body to deactivate. This is the most common inherited thrombophilia in people of European ancestry.
  • Prothrombin gene mutation (also called prothrombin G20210A): a change that leads to higher-than-normal levels of prothrombin, a protein that helps form clots.
  • Protein C deficiency: too little, or poorly working, protein C, a natural anticoagulant (a substance that limits clotting).
  • Protein S deficiency: too little, or poorly working, protein S, which helps protein C do its job.
  • Antithrombin deficiency: too little, or poorly working, antithrombin, one of the body’s most important anticlotting proteins. This is rarer but tends to carry a higher risk than the more common changes.

These gene changes are usually passed on in what is called an autosomal dominant pattern, meaning a child who inherits one changed copy from one parent can have the condition. Each child of an affected parent typically has a 50 percent chance of inheriting that copy. Inheriting two changed copies, one from each parent, is less common and is generally associated with a higher clot risk.

Because the gene change alone is often not enough to cause a clot, additional risk factors matter a great deal. Situations that further raise the chance of clotting in someone with inherited thrombophilia include:

  • Major surgery, particularly orthopedic surgery on the hip or knee
  • Serious injury or a broken bone, especially with a cast or bed rest
  • Long periods of immobility, such as hospitalization or very long travel
  • Pregnancy and the weeks after giving birth
  • Estrogen-containing medicines, including some birth control pills and hormone replacement therapy
  • Cancer and some cancer treatments
  • Obesity, smoking, and increasing age
  • Having had a previous blood clot

Inherited thrombophilia diagnosis

Inherited thrombophilia diagnosis has two separate parts. First, if a clot is suspected, doctors need to confirm the clot itself. Second, they decide whether testing for an underlying genetic tendency is useful, and if so, which tests to order and when.

To confirm a clot, doctors usually rely on:

  • Compression ultrasound: a painless scan that uses sound waves to look at blood flow in the veins of the leg or arm. It is the usual first test for suspected DVT.
  • CT pulmonary angiography: a CT scan with contrast dye that shows the arteries of the lungs and is the standard imaging test for suspected pulmonary embolism.
  • D-dimer blood test: measures a breakdown product of clots. A normal result can help rule out a clot in low-risk patients, but a raised result is not specific and needs to be confirmed by imaging.
  • Other imaging, such as MRI or CT of the abdomen or brain, when a clot in an unusual location is suspected.

Testing for the inherited tendency itself is done with blood samples. The main tests are:

  • Genetic (DNA) tests for Factor V Leiden and the prothrombin gene mutation. These are reliable at any time, because the result does not change with illness or medication.
  • Activated protein C resistance test, a functional screen that often points toward Factor V Leiden and may be followed by a genetic test to confirm.
  • Protein C, protein S, and antithrombin levels. These are measured as activity or concentration in the blood. Results can be temporarily lowered by an acute clot, by pregnancy, by liver disease, or by anticoagulant medicines, so doctors often wait until the person has recovered and is off certain medicines, or repeat the test, before making a diagnosis.

Doctors do not test everyone who has a clot. Testing is more likely to be recommended when a clot occurs at a young age, without an obvious trigger, more than once, in an unusual site, or when there is a strong family history. Testing may also be considered for close relatives of a person with a known high-risk change, especially if the result would change decisions about hormone use, pregnancy care, or prevention around surgery. Genetic counseling is often offered so that the person understands what a result does and does not mean. Inherited thrombophilia is usually managed by a hematologist, a doctor who specializes in blood disorders; at Acibadem this falls under the Hematology Department.

Inherited thrombophilia treatment options

There is no treatment that removes or corrects the gene change. Inherited thrombophilia treatment therefore focuses on two goals: treating any clot that has formed, and lowering the chance of future clots in a way that balances benefit against the risk of bleeding from blood-thinning medicines.

Observation and risk-reduction. For many people who carry a gene change but have never had a clot, no daily medication is needed. Instead, doctors typically recommend awareness of warning signs, keeping active, maintaining a healthy weight, not smoking, and avoiding or carefully reviewing estrogen-containing medicines. Short-term preventive measures may be advised during high-risk periods such as surgery, hospitalization, or long journeys.

Anticoagulant medicines. When a clot is confirmed, the standard treatment is an anticoagulant, a medicine that slows the clotting process so the existing clot does not grow and new clots are less likely to form. Options include injected heparins, the older tablet warfarin (which needs regular blood monitoring), and newer direct oral anticoagulants that generally require less monitoring. The choice depends on the type of clot, kidney function, pregnancy status, other medicines, and personal preference. A first clot with a clear temporary trigger is often treated for a limited number of months. After an unprovoked clot, a repeated clot, or with a high-risk gene change such as antithrombin deficiency, doctors may discuss longer-term or indefinite treatment, weighing clot risk against bleeding risk for each individual.

Prevention during pregnancy. Pregnancy naturally increases clotting. Women with inherited thrombophilia may be offered injected heparin during pregnancy and for several weeks after delivery, depending on the gene change involved and their personal or family history. Warfarin is generally avoided during pregnancy because it can harm the developing baby. These decisions are usually made jointly by obstetric and hematology teams.

Procedures. Procedures are not a treatment for the inherited tendency itself, but they may be used for specific clots. In selected cases of very large or limb-threatening clots, doctors may use catheter-directed treatment, in which a thin tube delivers clot-dissolving medicine directly into the clot, or mechanical clot removal. A filter placed in the main abdominal vein may occasionally be used when anticoagulants cannot be given. Surgery to remove a clot is uncommon and reserved for particular situations.

Rehabilitation and follow-up. After a DVT, some people develop post-thrombotic syndrome, long-lasting leg pain, swelling, and skin changes caused by damage to the vein valves. Compression stockings, leg elevation, and regular walking are often suggested to ease symptoms, although evidence on how well stockings prevent the syndrome is mixed. After a pulmonary embolism, follow-up may include checking that breathing has returned to normal and, in a small number of people, tests for lingering pressure in the lung arteries.

Living with inherited thrombophilia and outlook

For most people, inherited thrombophilia is a manageable condition rather than a life-limiting one. Many carriers never develop a clot, and those who do generally recover well once the clot is treated. The outlook depends on which gene change is present, whether one or two copies are involved, whether a clot has already occurred, and how many additional risk factors are present. Antithrombin deficiency and combined defects carry a higher lifetime risk than a single copy of Factor V Leiden or the prothrombin mutation.

Living with the condition usually means being informed rather than anxious. Practical steps often include telling every doctor, dentist, and surgeon about the diagnosis, wearing medical identification if on long-term anticoagulants, planning ahead for surgery or travel, and discussing contraception and pregnancy plans early with a doctor who knows the history. People taking anticoagulants also learn to watch for bleeding, to be careful with activities that carry a high risk of injury, and to check with a pharmacist before starting new medicines or supplements, since some interact with blood thinners.

Family members may wish to consider testing, and it is reasonable to discuss this with a doctor or genetic counselor. Knowing a relative’s status can inform decisions, but a negative test does not remove all clot risk, and a positive test does not mean a clot is inevitable. Honest, individualized conversations with a hematologist are the most reliable way to understand what a diagnosis means for a particular person.

Frequently asked questions

What are the first inherited thrombophilia symptoms to watch for?

The condition itself is silent, so the first sign is usually a clot. For a leg clot this is often one-sided swelling, calf pain, and warmth; for a lung clot it is sudden breathlessness or chest pain. Anyone with a known gene change who develops these symptoms should seek medical care promptly rather than waiting to see if they settle.

What causes inherited thrombophilia, and can it skip a generation?

It is caused by gene changes that affect the balance of clotting proteins, most often Factor V Leiden, the prothrombin mutation, or deficiencies of protein C, protein S, or antithrombin. These are usually passed on in a dominant pattern, so a parent with one changed copy has roughly a 50 percent chance of passing it to each child. Because carriers often never have a clot, it may appear to skip a generation even though the gene was present.

How is inherited thrombophilia diagnosis made if I have never had a clot?

Diagnosis without a clot relies on blood tests, either genetic tests for Factor V Leiden and the prothrombin mutation or measurements of protein C, protein S, and antithrombin. Doctors generally test only when there is a good reason, such as a close relative with a known change, and often involve genetic counseling so the result is understood in context.

Does inherited thrombophilia treatment mean lifelong blood thinners?

Not usually. People who have never had a clot typically do not take daily anticoagulants; they use preventive measures during high-risk periods instead. After a first clot with a clear trigger, treatment is often limited to several months. Long-term treatment is more likely after unprovoked or repeated clots, or with higher-risk gene changes, and the decision is individual.

Can I take birth control pills with inherited thrombophilia?

Estrogen-containing contraceptives raise clot risk, and that increase is larger in people with inherited thrombophilia. Many doctors advise avoiding combined estrogen pills and choosing progestin-only or non-hormonal methods instead. The right choice depends on the specific gene change, personal and family history, and other health factors, so it should be discussed with a doctor.

Is pregnancy safe with inherited thrombophilia?

Many women with inherited thrombophilia have healthy pregnancies. Because pregnancy increases clot risk, doctors may recommend injected heparin during pregnancy and after delivery, depending on the gene change and history. Warfarin is generally avoided in pregnancy. Early planning with obstetric and hematology teams helps tailor care.

Should my children be tested for inherited thrombophilia?

There is no single answer. Testing children is often deferred until adolescence or adulthood, when results could influence decisions about hormones, pregnancy, or surgery, unless there is a specific medical reason to test earlier. A doctor or genetic counselor can help weigh the benefits and limitations for a particular family.

When to see a doctor

If you know you have inherited thrombophilia, or have a strong family history of clots, it is sensible to arrange a routine appointment to discuss your individual risk, especially before planned surgery, before starting hormone-containing medicines, when planning a pregnancy, or before a very long journey. You should also see a doctor if you develop persistent, unexplained swelling or pain in one limb, even if mild.

Seek emergency care immediately if you experience any of the following red-flag warning signs:

  • Sudden shortness of breath or difficulty breathing
  • Sharp chest pain, especially pain that worsens with deep breaths
  • Coughing up blood
  • Fainting, near-fainting, or a racing heartbeat with breathlessness
  • Rapidly increasing swelling, pain, or color change in one leg or arm
  • Sudden severe headache, confusion, vision loss, weakness on one side of the body, or trouble speaking
  • Severe abdominal pain with vomiting, particularly if on hormone treatment or pregnant
  • If you take anticoagulants: heavy or unstoppable bleeding, black or bloody stools, vomiting blood, or a head injury

These symptoms can indicate a pulmonary embolism, a clot in the brain or abdomen, or serious bleeding, all of which need urgent assessment. Acting quickly gives the best chance of effective treatment.

Add Acıbadem on Google

Add us as a Preferred Source to see more of our trusted health content across Google Search, AI Overviews and Discover.

Share this page

Medically reviewed by the Acıbadem International Medical Board — September 13, 2026
See our medical review board →

Published: September 13, 2026Last updated: September 13, 2026
Update history
  • PublishedSeptember 13, 2026
  • Medical review approvedSeptember 13, 2026
  • Last content updateSeptember 13, 2026
References2
  1. medlineplus.gov
  2. medlineplus.gov
Treatments

Treatments for This Condition

Departments

Care at Acibadem

Specialists

Doctors Who Treat This Condition

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.